New bisphosphonate approved for Paget's disease.
D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D004164:Diphosphonates; C058651:tiludronic acid